Peripheral airway obstruction in primary pulmonary hypertension

F J Meyer, R Ewert, M M Hoeper, H Olschewski, J Behr, J Winkler, H Wilkens, C Breuer, W Kübler, M M Borst, German PPH Study Group, F J Meyer, R Ewert, M M Hoeper, H Olschewski, J Behr, J Winkler, H Wilkens, C Breuer, W Kübler, M M Borst, German PPH Study Group

Abstract

Background: As there is controversy about changes in lung function in primary pulmonary hypertension (PPH), lung mechanics were assessed with a focus on expiratory airflow in relation to pulmonary haemodynamics.

Methods: A cross sectional study was performed in 64 controls and 171 patients with PPH (117 women) of mean (SD) age 45 (13) years, pulmonary artery pressure (PAPmean) 57 (15) mm Hg, and pulmonary vascular resistance 1371 (644) dyne.s/cm(5).

Results: Mean (SD) total lung capacity was similar in patients with PPH and controls (98 (12)% predicted v 102 (17)% predicted, mean difference -4 (95% confidence interval (CI) -7.89 to -0.11); residual volume (RV) was increased (118 (24)% predicted v 109 (27)% predicted, mean difference 9 (95% CI 1.86 to 16.14); and vital capacity (VC) was decreased (91 (16)% predicted v 102 (10)% predicted, mean difference -11 (95% CI 15.19 to -6.80). RV/TLC was increased (117 (27)% predicted v 97 (29)% predicted, mean difference 20 (95% CI 12.3 to 27.8)) and correlated with PAPmean (r=0.31, p<0.001). In patients with PAPmean above the median of 56 mm Hg, RV/TLC was further increased (125 (32)% predicted v 111 (22)% predicted, mean difference -14 (95% CI -22.2 to -5.8)). Expiratory flow-volume curves were reduced and curvilinear in patients with PPH.

Conclusions: Peripheral airway obstruction is common in PPH and is more pronounced in severe disease. This may contribute to symptoms. Reversibility of bronchodilation and relation to exercise capacity need further evaluation.

References

    1. Thorax. 1999 Dec;54(12):1107-18
    1. Circulation. 1964 Jun;29:825-32
    1. Ann Intern Med. 2000 Mar 21;132(6):435-43
    1. Basic Res Cardiol. 2000 Aug;95(4):333-42
    1. Z Kardiol. 2000 Nov;89(11):987-99
    1. Circulation. 2001 May 1;103(17):2153-8
    1. Respir Res. 2001;2(2):90-101
    1. J Appl Physiol. 1967 Nov;23(5):646-62
    1. Am J Med. 1969 Sep;47(3):378-83
    1. Br Heart J. 1974 Jan;36(1):19-28
    1. Am Rev Respir Dis. 1978 Aug;118(2):409-13
    1. Chest. 1983 May;83(5):732-8
    1. Br Med J (Clin Res Ed). 1983 May 7;286(6376):1489-93
    1. Am Rev Respir Dis. 1983 Jul;128(1):163-5
    1. Ann Intern Med. 1987 Aug;107(2):216-23
    1. Thorax. 1987 Feb;42(2):131-5
    1. J Appl Physiol (1985). 1991 Jan;70(1):384-90
    1. J Appl Physiol (1985). 1991 Feb;70(2):561-6
    1. N Engl J Med. 1991 May 30;324(22):1539-47
    1. Eur J Pharmacol. 1992 Jan 14;210(2):221-2
    1. Eur Heart J. 1993 Jun;14(6):744-50
    1. Am J Cardiol. 1994 Feb 1;73(4):258-62
    1. N Engl J Med. 1995 Jul 27;333(4):214-21
    1. Clin Pediatr (Phila). 1999 Jan;38(1):27-33
    1. Am J Respir Crit Care Med. 1999 Aug;160(2):535-41
    1. J Am Coll Cardiol. 2000 Jan;35(1):176-82

Source: PubMed

3
Suscribir